Phibro Animal Health Corporation (PAHC) - Stock Analysis
Last updated: Jan 14, 2026
Research Idea
Research content for general circulation. Not individualized advice. Methodology & Disclosures
Phibro Animal Health exhibits strong earnings growth, margin expansion, cash flow strength, and a 42% price surge over the last month, making it a hot short-term idea with a solid fundamental and technical growth profile.
Loading chart data...
AI Analyst Overview
Loading chart data...
Valuation Metrics
Fundamental Analysis
Key Financial Insights: ⢠Improving margins ⢠Elevated leverage ⢠Volatile FCF PAHC shows materially improving margins and strong liquidity but is constrained by high leverage, large inventory and uneven free cash flow, which temper the investment case.
Price Behavior
Key Price Behavior Insights: ⢠Downtrend pressure ⢠Failed rallies ⢠Solid floor Support Level: $37.30â$37.80 Resistance Level: $41â$42 PAHC has weakened over the last month from a midâNovember high into a low near $37.30, showing selling pressure with a recent bounce toward $40.46 but stalled at $41â$42 resistance.
Sentiment & News
Key News Insights: ⢠Vaccine growth ⢠CEO succession ⢠Insider/institutional Phibro Animal Health (PAHC) is being flagged as a balanced value-and-growth pick driven by vaccine/animal-health momentum, a planned CEO succession, mixed "Hold" analyst sentiment, and notable insider/institutional trades.
AI Summary
PAHC has shifted into a deal-driven integration and margin-recovery story postâMFA, so the investment now hinges on management's ability to quickly cut inventory, normalize cash conversion and reduce leverageâif they succeed the current multiples (fair value ~\$43) are defendable, but persistent high inventory, lumpy MFA volumes or rising interest costs would materially compress valuation.
Description
Phibro Animal Health Corporation manufactures and sells a range of animal health and mineral nutrition products for livestock, operating through Animal Health, Mineral Nutrition, and Performance Products segments. Its portfolio includes pharmaceutical treatments and vaccines for poultry, swine and cattle, nutritional additives and trace mineral formulations, plus specialty ingredients used in non-food industries. The company distributes products to integrators, feed manufacturers and distributors across North America, Latin America, Europe, the Middle East, Africa and the Asia Pacific from its headquarters in Teaneck, New Jersey.
Idea History
| Date | Close | Ticker | Company | Summary | Status | P/L |
|---|---|---|---|---|---|---|
| Sep 2 | Sep 9 | PAHC | Phibro Animal Health Corporation | Phibro Animal Health exhibits strong earnings growth, margin expansion, cash flow strength, and a 42% price surge over the last month, making it a hot short-term idea with a solid fundamental and technical growth profile. | Closed | +12.8% |